North America 3D Cell Culture Market 2019-2027 – Increasing Usage of 3D Cell Culture In Organ Transplantation and Drug Screening – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America 3D Cell Culture Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering.

The industry will grow progressively in terms of revenue, at a CAGR of 12.13% for the forecast duration from 2019-2027.

The United States and Canada together constitute the 3D cell culture market in North America. The North American region holds the highest share in the 3D cell culture market, which can be attributed to the rise in the demand for 3D cell culture and the market expansion in the region. 3D cellular models offer more predictive results for in-vivo tests, which makes the 3D cell culture technology a better alternative to traditional cell culture.

In addition, 3D cell culturing enables drug discovery to provide greater efficacy with respect to toxicity screening of drugs, which is boosting revenues of this segment. Furthermore, the rising incidence of diseases, in spite of exemplary improvements in therapies, has raised the demand for advancements in drug discovery & development.

The developing infrastructure and the presence of international funding organizations in this region have also been instrumental in enhancing the demand for 3D cell culture systems. These factors serve as the drivers for the growth of the 3D cell culture market in North America.

Few of the prime players in the 3D cell culture market are Corning Inc., Nano3D Biosciences, Inc., GE Healthcare, Merck KGaA, Becton Dickinson and Company, Lonza Group AG, and Synthecon, Incorporated.

Key Topics Covered:

1. North America 3D Cell Culture Market – Summary

2. Industry Outlook

2.1. Market Definition

2.2. Porter’S Five Forces Model

2.3. Economic Technological, And Political & Legal Outlook

2.4. Regulatory Outlook

2.5. Key Insight

2.6. Market Drivers

2.6.1. Growing Cancer Prevalence

2.6.2. High Demand For Organ Transplantation

2.6.3. Promising Developments Using Regenerative Medicine

2.7. Market Restraints

2.7.1. Lack Of Skilled Professionals

2.7.2. Incompatibilities Of The Preferred Analytical Technologies With 3D Cell Culture

2.8. Market Opportunities

2.8.1. Increasing Usage Of 3D Cell Culture In Organ Transplantation And Drug Screening

2.8.2. Technological Advancement

2.9. Market Challenges

2.9.1. Lack Of Availability Of Data For Research On 3D Cell Culture

2.9.2. Challenges Associated With 3D Cell Culture In Performing Experiments

3. 3D Cell Culture Market Outlook – By Technology

3.1. Scaffold-Based

3.1.1. Hydrogels

3.1.2. Polymeric Scaffolds

3.1.3. Micropatterned Surface Microplates

3.2. Scaffold-Free

3.2.1. Hanging Drop Microplates

3.2.2. Spheroid Microplates Containing Ultra-Low Attachment (Ula) Coating

3.2.3. Microfluidic 3D Cell Culture

3.2.4. Magnetic Levitations & 3D Bioprinting

3.3. 3D Bioreactors

4. 3D Cell Culture Market Outlook – By Application

4.1. Cancer

4.2. Tissue Engineering & Immunohistochemistry

4.3. Drug Development

4.4. Stem Cell Research

4.5. Other Applications

5. 3D Cell Culture Market Outlook – By Component

5.1. Media

5.2. Reagents And Consumables

6. 3D Cell Culture Market Outlook – By End-User

6.1. Biotechnology And Pharmaceutical Organizations

6.2. Research Laboratories And Institutes

6.3. Hospitals And Diagnostic Centers

6.4. Other End-Users

7. 3D Cell Culture Market – Regional Outlook

7.1. North America

7.1.1. Country Analysis

7.1.1.1. The United States

7.1.1.2. Canada

8. Company Profiles

8.1. Becton Dickinson And Company

8.2. Tecan Group Ltd.

8.3. Promocell Gmbh

8.4. Corning Inc.

8.5. Nano3D Biosciences, Inc.

8.6. 3D Biotek, Llc

8.7. Merck Kgaa

8.8. Emulate

8.9. Thermo Fisher Scientific, Inc.

8.10. Ge Healthcare

8.11. Insphero

8.12. Lonza Group Ag

8.13. Vwr Corporation

8.14. Synthecon, Incorporated

For more information about this report visit https://www.researchandmarkets.com/r/4x64c1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900